VIR
Vir Biotechnology Inc.
Company Overview
| Mkt Cap | $795.99M | Price | $5.96 |
| Volume | 1.01M | Change | +0.51% |
| P/E Ratio | -1.5 | Open | $5.87 |
| Revenue | $74.2M | Prev Close | $5.93 |
| Net Income | $-522.0M | 52W Range | $4.16 - $14.45 |
| Div Yield | N/A | Target | $17.22 |
| Overall | 59 | Value | 60 |
| Quality | -- | Technical | 58 |
No chart data available
Stock Overview
Updated DailyVir Biotechnology Inc. (VIR) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $5.96 with a market capitalization of $795.99 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows VIR with a volume of 1.01 million shares. The stock opened down 1.01% from yesterday's close of $5.93. Current analyst estimates project earnings of $-3.11 per share for this year, with next year targeting $-2.73.
VIR demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for VIR include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 188.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 11:03 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $5.96 | +0.5% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |